BARICICH, Alessio
 Distribuzione geografica
Continente #
EU - Europa 2.722
NA - Nord America 1.799
AS - Asia 608
SA - Sud America 17
AF - Africa 9
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.162
Nazione #
US - Stati Uniti d'America 1.761
IE - Irlanda 824
IT - Italia 523
SE - Svezia 361
FR - Francia 300
DE - Germania 277
UA - Ucraina 216
SG - Singapore 152
CN - Cina 139
HK - Hong Kong 120
FI - Finlandia 89
IN - India 53
IR - Iran 44
CA - Canada 38
GB - Regno Unito 37
VN - Vietnam 33
CZ - Repubblica Ceca 23
BE - Belgio 22
NL - Olanda 14
ES - Italia 10
PK - Pakistan 10
TR - Turchia 9
KR - Corea 8
PE - Perù 8
JP - Giappone 7
MY - Malesia 7
PH - Filippine 6
AU - Australia 5
TH - Thailandia 5
TW - Taiwan 5
BR - Brasile 4
MO - Macao, regione amministrativa speciale della Cina 4
RS - Serbia 4
ZA - Sudafrica 4
CH - Svizzera 3
CL - Cile 3
EG - Egitto 3
GR - Grecia 3
LT - Lituania 3
AR - Argentina 2
BD - Bangladesh 2
BG - Bulgaria 2
EU - Europa 2
LI - Liechtenstein 2
PL - Polonia 2
RO - Romania 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
KE - Kenya 1
KH - Cambogia 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
RU - Federazione Russa 1
SN - Senegal 1
Totale 5.162
Città #
Dublin 817
Jacksonville 392
Dearborn 168
Chandler 161
Wilmington 117
Singapore 107
Hong Kong 106
Princeton 99
Lawrence 98
Ann Arbor 86
Piemonte 70
San Mateo 67
Beijing 61
Ashburn 39
Turin 39
Andover 31
Milan 31
Boardman 30
Dong Ket 30
Helsinki 28
Bremen 27
Vercelli 25
Munich 23
Brussels 22
Brno 21
Novara 17
Nanjing 15
Rome 13
Zanjan 13
Woodbridge 12
Toronto 11
Fairfield 10
Kunming 10
Chennai 9
Frankfurt am Main 9
Hefei 9
Houston 8
Montreal 8
Norwalk 8
Tehran 8
Bari 7
Monmouth Junction 7
Sham Shui Po 7
Strasbourg 7
Villa Cortese 7
Alessandria 6
Amsterdam 6
Leawood 6
New York 6
Santa Clara 6
Shenyang 6
West Jordan 6
Bangkok 5
Chimbote 5
Grafing 5
Lappeenranta 5
London 5
Monza 5
Mülheim 5
Naples 5
Paris 5
Sacramento 5
Zhengzhou 5
Ardabil 4
Berlin 4
Cagliari 4
Guangzhou 4
Johannesburg 4
Los Angeles 4
Macao 4
Marseille 4
Olgiate Comasco 4
Palermo 4
Philadelphia 4
Senigallia 4
Sydney 4
Vancouver 4
Winnipeg 4
Athens 3
Augusta 3
Bien Hoa 3
Borgomanero 3
Busanjin-gu 3
Cassano Magnago 3
Goyang-si 3
Greenville 3
Guelph 3
Ipoh 3
Jinan 3
Leipzig 3
Lima 3
Menlo Park 3
Minervino Murge 3
Mumbai 3
New Taipei City 3
Noicattaro 3
Odalengo Grande 3
Ottawa 3
Pioltello 3
Plymouth 3
Totale 3.113
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 243
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 145
Clinical and instrumental evaluation of Botulinum Toxin type A safety profile in post stroke spasticity rehabilitation treatment 140
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 104
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 95
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 91
ONCE YEARLY ZOLEDRONIC ACID AFTER 18 MONTHS OF PARATHYROID HORMONE (1-84) FOR SEVERE OSTEOPOROSIS 83
Effects of Denosumab on Bone Turnover Markers compared to Zoledronic Acid in severe osteoporotic women: a randomized head to head study 82
Sarcopenic dysphagia: a narrative review 80
MULTIMODAL ANALGESIA AND REHABILITATION PROTOCOL IN TOTAL KNEE REPLACEMENT: A PILOT STUDY 75
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 69
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 69
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 68
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 67
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 66
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 64
Peripheral facial nerve palsy: how effective is rehabilitation? 62
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 62
Efficacy of a Hip Flexion Assist Orthosis in Adults With Hemiparesis After Stroke. 60
Chronic stroke: an oxymoron or a challenge for rehabilitation? 59
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 59
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 57
Once yearly Zoledronic Acid in Osteoporotic PD Patients compared to agematched osteoporotic post menopausal women 57
Once Yearly Zoledronic Acid After 18 months of Parathyroid Hormone (1-84) for Severe Osteoporosis 55
Administration of type a botulinum toxin after total hip replacement 55
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 54
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 54
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 53
Sonographic and clinical effects of botulinum toxin Type A combined with extracorporeal shock wave therapy on spastic muscles of children with cerebral palsy 53
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 53
Efficacy and safety of a hip flexion assist orthosis in adult hemiplegic stroke patients 52
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial. 52
Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE 52
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 51
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 51
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 51
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 51
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 51
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 50
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 48
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection. 48
Risk factors and outcome in falls 48
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 48
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 46
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 45
People with Spinal Cord Injury in Italy 45
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 45
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 45
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial. 45
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial. 45
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 45
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 44
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 44
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 44
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 43
Post-stroke spasticity as a condition: A new perspective on patient evaluation 43
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 43
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 42
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 42
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 42
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 41
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 41
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects 41
The past and future of Functional Neurology 41
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 41
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 41
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 40
Management of spasticity with onabotulinumtoxinA: Practical guidance based on the Italian real-life post-stroke spasticity survey 40
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 40
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 39
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 39
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 39
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 39
Esercizio e terza età 38
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 38
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 38
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study 38
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 38
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 38
Ultrasound-guided injection of botulinum toxin type a for piriformis muscle syndrome: A case report and review of the literature 37
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 36
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 36
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 36
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 36
The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A 35
ROLE OF EARLY BOTULINUM TOXIN TYPE A INJECTION IN THE TREATMENT OF PATIENTS WITH POSTSTROKE SPASTICITY: PRELIMINARY RESULTS OF AN OBSERVATIONAL STUDY 35
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 34
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE 34
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE 34
Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials 32
RE: Impact of instrumental analysis of stiff knee gait on treatment appropriateness and associated costs in stroke patients 29
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 28
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 26
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 26
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 24
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 24
Tolerability, Safety and Efficacy of a Specific Rehabilitation Treatment Protocol for Axillary Web Syndrome: An Observational Retrospective Study 24
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 23
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 23
Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations 23
Totale 5.120
Categoria #
all - tutte 35.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020560 0 0 0 0 0 132 136 47 94 68 77 6
2020/2021627 74 2 79 0 72 23 90 14 80 46 98 49
2021/2022905 41 13 148 67 57 54 52 52 62 61 119 179
2022/20231.644 129 79 74 35 91 147 52 87 810 18 68 54
2023/2024833 61 48 49 27 105 29 150 62 19 61 75 147
2024/2025264 49 24 68 32 55 36 0 0 0 0 0 0
Totale 5.365